Navigation Links
Press statement on new CDC MRSA study from SHEA president

A new study from the Centers for Disease Control and Prevention (CDC) shows a decrease in catheter-associated bloodstream infections caused by both methicillin-resistant and methicillin-sensitive S. aureus. The 10-year national study, 'Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units, 1997,' reported data from both the National Nosocomial Infection Surveillance (NNIS) and its successor, the National Healthcare Safety Network (NHSN). The study demonstrates a steady decline in intensive care unit catheter-associated MRSA bloodstream infections since 2001.

Below Are Quotes from Mark Rupp, MD, President of SHEA

"Despite the fact that MRSA prevalence continues to rise, efforts to prevent catheter infections are paying dividends and the number of infections due to all types of Staphylococcus aureus, including MRSA, have been falling sharply since 2001. Therefore, simply examining the percentage of staphylococcal isolates that are MRSA can be a misleading indicator of the burden of disease caused by this organism."

"The rate of these infections is decreasing and hospitals are becoming safer for patients because hospitals are instituting and adhering to general practices that result in fewer infections, including measures to ensure proper catheter insertion and removal, hand hygiene, environmental cleanliness, and antimicrobial stewardship.

"Because MRSA only causes about 8% of healthcare-associated infections, it is critical that we not concentrate all of our preventive efforts on a single bacterium. Undue emphasis on a single organism like MRSA can dilute broader-based measures that can have a dramatic effect on infections caused by many different organisms.

"This study illustrates that it is more important for hospitals to focus on the infections and diseases that the germs cause rather than the germs themselves. Decreasing the infections will decrease the burden of disease caused by all resistant organisms and not just MRSA."


Contact: Sharon Reis

Related biology news :

1. Molecule that suppresses immune response under study in type 1 diabetes
2. UNC study: Tinkering with the circadian clock can suppress cancer growth
3. Pregnancy hormone predicts postpartum depression
4. American Chemical Societys Weekly PressPac -- Jan. 28, 2009
5. DNA component can stimulate and suppress the immune response
6. Cutting salt isnt the only way to reduce blood pressure
7. American Chemical Societys weekly PressPac -- Jan. 14, 2009
8. American Chemical Societys Weekly PressPac -- Jan. 7, 2009
9. Facial expressions of emotion are innate, not learned, says new study
10. Krumlauf Lab demonstrates modulation of gene expression by protein coding regions
11. American Chemical Societys Weekly PressPac -- Dec. 17, 2008
Post Your Comments:
(Date:10/29/2015)... Daon, a global leader in mobile biometric ... new version of its IdentityX Platform , IdentityX ... have already installed IdentityX v4.0 and are ... FIDO UAF certified server component as an option ... features. These customers include some of the largest and ...
(Date:10/29/2015)... 29, 2015  Connected health pioneer, Joseph C. ... of technology-enabled health and wellness, and the business opportunities ... The Internet of Healthy Things . Long ... even existed, Dr. Kvedar, vice president, Connected Health, Partners ... delivery, moving care from the hospital or doctor,s office ...
(Date:10/29/2015)... Oct. 29, 2015 Today, LifeBEAM ... partnership with 2XU, a global leader in technical ... smart hat with advanced bio-sensing technology. The hat ... to monitor key biometrics to improve overall training ... the two companies will bring together the most advanced ...
Breaking Biology News(10 mins):
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
Breaking Biology Technology: